Ocugen Total Liab from 2010 to 2025

OCGN Stock  USD 0.73  0.04  5.53%   
Ocugen Total Liabilities yearly trend continues to be very stable with very little volatility. Total Liabilities is likely to drop to about 18.9 M. Total Liabilities is the total amount of all liabilities that Ocugen Inc has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2013-12-31
Previous Quarter
23.6 M
Current Value
21.3 M
Quarterly Volatility
19.7 M
 
Yuan Drop
 
Covid
Check Ocugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocugen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 582.4 K, Interest Expense of 4.2 M or Selling General Administrative of 38.6 M, as well as many indicators such as Price To Sales Ratio of 25.43, Dividend Yield of 0.0 or PTB Ratio of 3.27. Ocugen financial statements analysis is a perfect complement when working with Ocugen Valuation or Volatility modules.
  
Check out the analysis of Ocugen Correlation against competitors.

Latest Ocugen's Total Liab Growth Pattern

Below is the plot of the Total Liab of Ocugen Inc over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Ocugen's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocugen's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Ocugen Total Liab Regression Statistics

Arithmetic Mean25,363,882
Geometric Mean19,480,199
Coefficient Of Variation82.37
Mean Deviation13,894,934
Median22,303,000
Standard Deviation20,892,955
Sample Variance436.5T
Range84.6M
R-Value(0.48)
Mean Square Error360.1T
R-Squared0.23
Significance0.06
Slope(2,104,408)
Total Sum of Squares6547.7T

Ocugen Total Liab History

202518.9 M
202421.6 M
202324 M
202224.6 M
20219.9 M
20205.8 M
20195.8 M

About Ocugen Financial Statements

Ocugen investors utilize fundamental indicators, such as Total Liab, to predict how Ocugen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities21.6 M18.9 M
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:
Check out the analysis of Ocugen Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.19)
Revenue Per Share
0.018
Quarterly Revenue Growth
1.353
Return On Assets
(0.48)
Return On Equity
(1.03)
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.